Galt enzyme deficiency identification in newborns in Azerbaijan

Автор: Hajiyeva Nilufar

Журнал: Бюллетень науки и практики @bulletennauki

Рубрика: Медицинские науки

Статья в выпуске: 9 т.8, 2022 года.

Бесплатный доступ

For the first time in Baku, Azerbaijan Republic in maternity houses by means of immunoenzyme analysis the genetic screening for galactosemia inherited metabolism disorder was carried out, and 3 newborns with GALT gene deficiency for were identified.

Duarte galactosemia, metabolism disorder, enzyme of galactose-1-phosphaturidyltransferase, polymerase chain reaction, mutation

Короткий адрес: https://sciup.org/14125319

IDR: 14125319   |   DOI: 10.33619/2414-2948/82/32

Список литературы Galt enzyme deficiency identification in newborns in Azerbaijan

  • Report of scientific group of World Health Organization. (1997). Fight with hereditary diseases. Jeneva, .P 133.
  • Berry, G. T. (2012). Galactosemia: when is it a newborn screening emergency?. Molecular genetics and metabolism, 106(1), 7-11. https://doi.org/10.10167j.ymgme.2012.03.007
  • Berry, G. T. (2015). Disorders of galactose metabolism. In Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (pp. 615-626). Academic Press. https://doi.org/10.1016/B978-0-12-410529-4.00055-3
  • National Organization for Rare Disorders. (2003). NORD guide to rare disorders. Lippincott Williams & Wilkins.
  • Bosch, A. M. (2006). Classical galactosaemia revisited. Journal of Inherited Metabolic Disease: Official Journal of the Society for the Study of Inborn Errors of Metabolism, 29(4), 516525. https://doi .org/10.1007/s 10545-006-0382-0
  • Karadag, N., Zenciroglu, A., Eminoglu, F. T., Dilli, D., Karagol, B. S., Kundak, A., ... & Okumus, N. (2013). Literature review and outcome of classic galactosemia diagnosed in the neonatal period. Clinical Laboratory, 59(9-10), 1139-1146. https://doi.org/10.7754/clin.lab.2013.121235
  • Doyle, C. M., Channon, S., Orlowska, D., & Lee, P. J. (2010). The neuropsychological profile of galactosaemia. Journal of inherited metabolic disease, 33(5), 603-609. https://doi.org/10.1007/s10545-010-9154-y
  • Schweitzer, S. (1995). Newborn mass screening for galactosemia. European Journal of Pediatrics, 154(2), S37-S39. https://doi.org/10.1007/BF02143801
  • Gu, W., Zhang, F., & Lupski, J. R. (2008). Mechanisms for human genomic rearrangements. Pathogenetics, 1(1), 1-17. https://doi.org/10.1186/1755-8417-1-4
  • Karadag, N., Zenciroglu, A., Eminoglu, F. T., Dilli, D., Karagol, B. S., Kundak, A., ... & Okumus, N. (2013). Literature review and outcome of classic galactosemia diagnosed in the neonatal period. Clinical Laboratory, 59(9-10), 1139-1146. https://doi.org/10.7754/clin.lab.2013.121235
  • Waisbren, S. E., Potter, N. L., Gordon, C. M., Green, R. C., Greenstein, P., Gubbels, C. S., ... & Berry, G. T. (2012). The adult galactosemic phenotype. Journal of Inherited Metabolic Disease: Official Journal of the Society for the Study of Inborn Errors of Metabolism, 35(2), 279286. https://doi.org/10.1007/s10545-011-9372-y
  • Shield, J. P. H., Wadsworth, E. J. K., MacDonald, A., Stephenson, A., Tyfield, L., Holton, J. B., & Marlow, N. (2000). The relationship of genotype to cognitive outcome in galactosaemia. Archives of disease in childhood, 53(3), 248-250.
  • Braulke, T., Raas-Rothschild, A., & Kornfeld, S. (2013). The online metabolic and molecular bases of inherited disease. I-cell Disease andPseudo-Hurler Polydystrophy: Disorders of lysosomal Enzyme Phosphorylation and Localization.
  • Hoffmann B, Dragano N, Schweitzer-Krantz S. (2012). Living situation, occupation and health-related quality of life in adult patients with classic galactosemia. J Inherit Metab Dis.;35:1051-8. [PubMed: 22447152].
  • Lai, K., Boxer, M. B., & Marabotti, A. (2014). GALK inhibitors for classic galactosemia. Future medicinal chemistry, 6(9), 1003-1015. https://doi.org/10.4155/fmc.14.43
  • Application information. Purification of GENO MELABTM GeXP Sequencing Productions using SPRI Clean SEQR Magnetic Beards. CEQ 2000, CEQ 2000XL, CEQ 8000, CEQ 8800 &GeXP Instruments BECKMAN COULTER. Application Team Europe.
  • Tang, M., Wierenga, K., Elsas, L. J., & Lai, K. (2010). Molecular and biochemical characterization of human galactokinase and its small molecule inhibitors. Chemico-biological interactions, 188(3), 376-385. https://doi.org/10.1016/j.cbi.2010.07.025
  • Pyhtila, B. M., Shaw, K. A., Neumann, S. E., & Fridovich-Keil, J. L. (2014). Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead. In JIMD Reports, Volume 15 (pp. 79-93). Springer, Berlin, Heidelberg. https://doi .org/10.1007/8904_2014_302
Еще
Статья научная